Nippon India Nifty (PHARMABEES) | Stock Overview & Key Data
Nippon India Nifty Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹24.65 on December 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
No peer performance data available for this stock.
Ownership & Short Interest
Nippon India Nifty Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Nippon India Nifty would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PHARMABEES's 52-week high and low?
- In the last 52 weeks, Nippon India Nifty reached a high of ₹24.65 (on January 3, 2025) and a low of ₹19.47 (on April 7, 2025).
- What is the market cap and P/E ratio for PHARMABEES?
- Curious about Nippon India Nifty's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does PHARMABEES pay dividends? If so, what's the yield?
- As for dividends, Nippon India Nifty isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nippon India Nifty's main competitors or similar companies to consider before investing?
When looking at Nippon India Nifty, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
No specific competitor data is currently available for comparison in this section.
- What are the key financial health indicators for Nippon India Nifty Pharma ETF? (e.g., ROE, Debt/Equity)
- To get a sense of Nippon India Nifty's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for PHARMABEES?
- Looking at Nippon India Nifty's growth, its revenue over the trailing twelve months (TTM) was INR0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of PHARMABEES stock is held by insiders and institutions?
- Wondering who owns Nippon India Nifty stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.